Pseudomembranous tracheobronchitis caused by Aspergillus in immunocompromised patients

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 11-12, 2005, Pages 937-942

  Chang, Shang Miao ^a   Kuo, Hsu Tah ^a   Lin, Fung J ^a   Tzen, Chi Yuan ^a   Sheu, Chin Yin ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; INSULIN; ITRACONAZOLE; MUCOLYTIC AGENT; PIPERACILLIN PLUS TAZOBACTAM; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS; BRONCHITIS; BRONCHOSCOPY; CASE REPORT; COUGHING; DEATH; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DISEASE COURSE; DYSPNEA; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; NONHUMAN; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; SEPSIS; SURVIVAL; THORAX PAIN; TRACHEITIS; TREATMENT PLANNING; UPPER RESPIRATORY TRACT OBSTRUCTION; WHEEZING;

ASPERGILLOSIS; ASPERGILLUS; BRONCHITIS; DIABETES COMPLICATIONS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED; TRACHEITIS;

EID: 30544454840     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540510044445     Document Type: Article

References (19)

1. Pennington, JE. (1980) Aspergillus lung disease Med Clin North Am, 64, 475-90.
2. Young, RC Bennett, JE Vogel, CL Carbone, PP De Vita, VT. (1970) Aspergillosis: The spectrum of disease in 98 patients Medicine, 49, 147-73.
3. Katzenstein, AL Liebow, AA Friedman, PJ. (1975) Bronchocentric granulomatosis, mucoid impaction and hypersensitivity reactions to fungi Am Rev Respir Dis, 111, 497-537.
4. Pervez, NK Kleinerman, J Kattan, M Freed, JA Harris, MB Rosen, MJ Schwartz, IS. (1985) Pseudomembranous necrotizing bronchial aspergillosis Am Rev Respir Dis, 131, 961-3.
5. Hines, DW Haber, MH Yaremko, L Britton, C Mclawhon, RW Harris, AA. (1991) Pseudomembranous tracheobronchitis caused by Aspergillus Am Rev Respir Dis, 6, 1408-11.
6. Lortholary, O Meyohas, M Dupont, B Cadranel, J Salmon-Ceron, D Peyramond, D Simonin, D. (1993) Invasive aspergillosis in the patient with acquired immunodeficiency syndrome: Report of 33 cases Am J Med, 95, 177-87.
7. Peterson, PK Mc Glave, P. Ramsay, NK. (1983) A prospective study of infectious diseases following bone marrow transplantation: Emergence of Aspergillus and cytomegalovirus as the major cause of mortality Infect Control, 4, 81-9.
8. Kemper, CA Hosteler, JS Follansbee, SE Ruane, P Covington, DC Leong, SS et al. (1993) Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS Clin Infect Dis, 7, 344-52.
9. Berlinger, NT Freeman, TJ. (1989) Acute airway obstruction due to necrotizing tracheobronchial aspergillosis in immunocompromized patients: A new clinical entity Ann Otol Rhino Larynogol, 98, 718-20.
10. Koh, LP Goh, YT Linn, YC Hwang, J Tan, P. (2000) Pseudomembranous tracheobronchitis caused by Aspergillus in a patient after peripheral blood stem cell transplantation Ann Acad Med Singapore, 29, 531-3.
11. Kramer, MR Denning, DW Marshall, SE Ross, DJ Berry, G Lewiston, NJ et al. (1991) Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis Am Rev Respir Dis, 144, 552-6.
12. Stevens, DA Kan, VL Judson, MA Morrison, VA Dummer, S Deinning, DW et al. (2000) Practice guidelines for disease caused by Aspergillus Clin Infect Dis, 30, 696-709.
13. Meersseman, W Vandecasteele, SJ Wilmer, A Verbeken, E Peetermans, WE Wijngaerden, EV. (2004) Invasive aspergillosis in the critically ill patients without malignancy Am J Respir Crit Care Med, 170, 621-5.
14. Denning, DW Kibbler, CC Barnes, RA British Society for Medical Mycology. (2003) British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections Lancet Inf Dis, 3 230-40.
15. Kuo, PH Lee, LN Yang, PC Chen, YC Luh, KT. (1996) Aspergillus laryngotracheobronchitis presenting as stridor in a patient with peripheral T-cell lymphoma Thorax, 51, 869-70.
16. Puttick, MPE Phillips, P. (1994) Itraconazole: Precautions regarding drug interactions and bioavailability Can J Infect Dis, 5, 179-83.
17. Schaffer, A Bohler, A. (1993) Amphotericin B refractory aspergillosis after itraconazole: Evidence for significant antagonism Mycoses, 36, 421-4.
18. Herbrecht, R Denning, DW Patterson, TF Bennett, JE Greene, RE Oestmann, JW et al. (2002) Randomized comparison of voriconazole and amphotericin B in primary therapy of invasive aspergillosis N Engl Med, 347, 408-15.
19. Ng, TT Robson, GD Denning, DW. (1994) Hydrocortisone-enhanced growth of Aspergillus spp: Implication for pathogenesis Microbiology, 140, 2475-9.